IL1B and myeloid sarcoma: In vivo and ex vivo studies in animal models of MS have shown that the pro-inflammatory cytokines IL-1β, TNF-α and IL-18 are involved in the synaptic loss of the disease, which may occur independently of demyelination and neuronal degeneration (45, 148).